31.40
+0.80
+(2.61%)
At close: January 31 at 5:26:51 PM GMT+1
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.97M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ST LEGER TINA AMBER Officer | Sale at price 64.06 per share. | Direct | 280,262 | Apr 1, 2024 |
| ST LEGER TINA AMBER Officer | Conversion of Exercise of derivative security at price 29.87 per share. | Direct | 130,681 | Apr 1, 2024 |
| BERMAN DAVID Officer | Sale at price 67.61 - 70.45 per share. | Direct | 2,504,158 | Feb 28, 2024 |
| BERMAN DAVID Officer | Conversion of Exercise of derivative security at price 17.46 per share. | Direct | 637,447 | Feb 28, 2024 |
| BERMAN DAVID Officer | Sale at price 69.45 - 71.97 per share. | Direct | 5,910,318 | Feb 27, 2024 |
| BERMAN DAVID Officer | Conversion of Exercise of derivative security at price 17.46 per share. | Direct | 1,457,753 | Feb 27, 2024 |
| ST LEGER TINA AMBER Officer | Sale at price 69.85 - 70.46 per share. | Direct | 305,781 | Jan 3, 2024 |
| ST LEGER TINA AMBER Officer | Conversion of Exercise of derivative security at price 29.87 per share. | Direct | 130,681 | Jan 3, 2024 |
Related Tickers
1JK.F Apellis Pharmaceuticals, Inc.
28.59
+3.40%
2L9.SG Blueprint Medicines Corp
107.90
-0.55%
LT4.F Liquidia Corporation
13.76
+1.33%
63E.MU Onward Medical NV
6.34
-6.49%
63E.F Onward Medical N.V.
6.50
-2.11%
ASEP.CN ASEP Medical Holdings Inc.
0.0650
-13.33%
5CV.F CureVac N.V.
3.6520
-1.78%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
CAMP CAMP4 THERAPEUTICS CORPORATION
4.8100
-18.47%